Opaleye Management Inc.'s Form 4 filing
Grace Therapeutics, Inc. (GRCE) · filed Sep 10, 2026
- Accession no.
- 0001493152-26-042152
- Filed
- Sep 10, 2026, 4:05 PM ET
- Trade date
- Sep 8-9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $31.9K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +9,393 | $2.10 | +$19,699 | 2,769,393 | Indirect | |
| Sep 9, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +5,836 | $2.09 | +$12,196.66 | 2,775,229 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.